Form 4: OHI Chief Legal Officer Converts Equity Awards

Omega Healthcare Investors' Chief Legal Officer, Gail D. Makode, converted 23,669 Profits Interest Units and 23,669 OP Units into common stock on September 30, 2025.

Summary

• Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors Inc. (OHI), executed several derivative security transactions on September 30, 2025.
• A total of 23,669 Profits Interest Units (PIUs) vested and were converted into an equal number of Operating Partnership Units (OP Units).
• Specifically, 11,627 PIUs vested based on Absolute Total Shareholder Return for the 2022-2024 performance period.
• Another 12,042 PIUs vested based on Relative Total Shareholder Return for the 2022-2024 performance period.
• Concurrently, 23,669 OP Units were converted into 23,669 shares of OHI common stock.
• Following these transactions, Makode beneficially owns 146,892 remaining PIUs and 317,854 remaining OP Units.
• Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of OHI common stock, or at the Issuer's election, one share of OHI common stock.

Sentiment

Score: 7

Explanation: The filing reflects positive news regarding executive compensation, as performance targets were met, leading to the vesting of equity awards. This indicates successful performance over the 2022-2024 period. However, it's a routine transaction and doesn't introduce new strategic initiatives or significant financial changes.

Positives

• The vesting of Profits Interest Units indicates the achievement of performance targets (Absolute and Relative Total Shareholder Return) for the 2022-2024 period.
• The conversion of derivative securities into common stock increases the Chief Legal Officer's direct equity stake in the company, aligning management and shareholder interests.

Risks

• The vesting of PIUs and conversion of OP Units are subject to continued employment, as stated in the explanations.
• The value of the converted common stock is subject to market fluctuations.

Future Outlook

The filing indicates that 25% of the PIUs vested at the end of each calendar quarter in 2025, suggesting further vesting events may occur throughout 2025 for the remaining PIUs, subject to continued employment and performance conditions.

Industry Context

This is a routine insider transaction filing (Form 4) for an executive converting equity awards. It reflects standard executive compensation practices in publicly traded companies, including REITs like Omega Healthcare Investors, where performance-based equity is a common incentive.

Comparison to Industry Standards

• The use of Profits Interest Units (PIUs) and Operating Partnership (OP) Units is standard for REITs structured with an UPREIT (Umbrella Partnership REIT) model, allowing for tax-efficient equity compensation.
• Performance-based vesting tied to Absolute and Relative Total Shareholder Return (TSR) is a common and widely accepted practice in executive compensation across various industries, including healthcare REITs, to align executive incentives with shareholder value creation.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value through direct equity ownership. The vesting indicates past performance targets were met.
• Employees: Demonstrates the company's commitment to performance-based compensation for its executives.

Next Steps

• Further vesting of the remaining PIUs may occur throughout 2025, subject to continued employment and performance conditions.

Key Dates

Recommendation

This Form 4 filing details a routine conversion of executive equity awards following the achievement of performance targets. While it indicates positive past performance and aligns executive interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for Omega Healthcare Investors. Investors should continue to hold based on broader company fundamentals and market conditions, rather than this specific insider transaction.

Keywords

Omega Healthcare Investors, OHI, Form 4, Insider Transaction, Equity Award, Profits Interest Units, OP Units, Common Stock, Gail D. Makode, Chief Legal Officer, Executive Compensation, Stock Vesting, Shareholder Return